Vol. 22 Suppl. 4 2007

Foreword

G. Gasparini

Int J Biol Markers 2007; 22(4): 1 - 2

Article type: FOREWORD free | PDF

The biology of epidermal growth factor receptor and its value as a prognostic/predictive factor

A.P. Dei Tos

Int J Biol Markers 2007; 22(4): 3 - 9

Article type: ORIGINAL ARTICLE free | PDF

Surrogate predictive biomarkers for response to anti-EGFR agents: state of the art and challenges

F. Cappuzzo, L. Toschi, G. Finocchiaro, C. Ligorio, A.. Santoro

Int J Biol Markers 2007; 22(4): 10 - 23

Article type: ORIGINAL ARTICLE | PDF

Pharmacology of epidermal growth factor inhibitors

G. Toffoli, E. De Mattia, E. Cecchin, P. Biason, S. Masier, G. Corona

Int J Biol Markers 2007; 22(4): 24 - 39

Article type: ORIGINAL ARTICLE | PDF

Development and clinical indications of cetuximab

R. Labianca, N. La Verde, M.C. Garassino

Int J Biol Markers 2007; 22(4): 40 - 46

Article type: ORIGINAL ARTICLE | PDF

The rationale for the combination of selective EGFR inhibitors with cytotoxic drugs and radiotherapy

G. Tortora, T. Gelardi, F. Ciardiello, R. Bianco

Int J Biol Markers 2007; 22(4): 47 - 52

Article type: ORIGINAL ARTICLE | PDF

Clinical management of cutaneous toxicity of anti-EGFR agents

M. Monti, S. Motta

Int J Biol Markers 2007; 22(4): 53 - 61

Article type: ORIGINAL ARTICLE | PDF

Cetuximab in colon cancer

F. Giuliani, G. Colucci

Int J Biol Markers 2007; 22(4): 62 - 70

Article type: ORIGINAL ARTICLE | PDF

Treatment of advanced head and neck cancer with cetuximab

M. Merlano, O. Garrone

Int J Biol Markers 2007; 22(4): 71 - 76

Article type: ORIGINAL ARTICLE | PDF

Rationale and clinical results of multi-target treatments in oncology

A. Sartore-Bianchi, R. Ricotta, G. Cerea, M.R. Maugeri, S. Siena

Int J Biol Markers 2007; 22(4): 77 - 87

Article type: ORIGINAL ARTICLE | PDF

The future of anti-EGFR therapy

M.R. D'Andrea, G. Gasparini

Int J Biol Markers 2007; 22(4): 88 - 93

Article type: ORIGINAL ARTICLE | PDF

Go back to top